Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB/C mice

Behavioural Brain Research

Volumn 270, Issue , 2014, Pages 86-94

  Pragnya, B ^a   Kameshwari, J S L ^a   Veeresh, B ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

Autism; Behavior; Mice; Piperine; Valproate

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; GLUTATHIONE; NITRIC OXIDE; PIPERINE; POLYSORBATE 80; SEROTONIN; VALPROIC ACID; 1,3 BENZODIOXOLE DERIVATIVE; ALKALOID; AMIDE; BIOLOGICAL MARKER; PIPERIDINE DERIVATIVE;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ANXIETY; ARTICLE; AUTISM; BEHAVIOR DISORDER; BRAIN PROTECTION; BRAIN SIZE; BRAIN TISSUE; CEREBELLUM; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; LOCOMOTION; MALE; MOUSE; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PERINATAL PERIOD; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; SEROTONIN BRAIN LEVEL; TASK PERFORMANCE; ANIMAL; AUTISTIC DISORDER; BAGG ALBINO MOUSE; BRAIN; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MOTOR PERFORMANCE; PATHOLOGY; PSYCHOLOGY; TIME; TREATMENT OUTCOME;

ALKALOIDS; ANIMALS; ANXIETY; AUTISTIC DISORDER; BENZODIOXOLES; BIOLOGICAL MARKERS; BRAIN; COGNITION; DISEASE MODELS, ANIMAL; LOCOMOTION; MICE; MICE, INBRED BALB C; MOTOR SKILLS; OXIDATIVE STRESS; PIPERIDINES; POLYUNSATURATED ALKAMIDES; TIME FACTORS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 84901339550     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.04.045     Document Type: Article

References (45)

1. Diagnostic and statistical manual of mental disorders. American Psychiatric Association 20004.
2. Chauhan A., Chauhan V. Oxidative stress in autism. Pathophysiology 2006, 13(3):171-181.
3. Kern J.K., Jones A.M. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 2006, 9(6):485-499.
4. Hranilovic D., Bujas-Petkovic Z., Vragovic R., Vuk T., Hock K., Jernej B. Hyperserotonemia in adults with autistic disorder. J Autism Dev Disord 2007, 37(10):1934-1940.
5. Hranilovic D., Bujas-Petkovic Z., Tomicic M., Bordukalo-Niksic T., Blazevic S., Cicin-Sain L. Hyperserotonemia in autism: activity of 5HT-associated platelet proteins. J Neural Transm 2009, 116(4):493-501.
6. Allen G. Cerebellar contributions to autism spectrum disorders. Clin Neurosci Res 2006, 6:195-207.
7. Bernard S., Enayati A., Redwood L., Roger H., Binstock T. Autism: a novel form of mercury poisoning. Med Hypotheses 2001, 56(4):462-471.
8. Chaste P., Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci 2012, 14(3):281-292.
9. Rodier P.M. Early environmental factors in autism. Ment Retard Dev D R 1998, 4:121-128.
10. Kini U. Fetal valproate syndrome: a review. Paediatr Perinat Drug Therapy 2006, 7(3):123-130.
11. Markram K., Rinaldi T., La M.D., Sandi C., Markram H. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 2008, 33(4):901-912.
12. Schneider T., Przewlocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005, 30(1):80-89.
13. Schneider T., Labuz D., Przewlocki R. Nociceptive changes in rats after prenatal exposure to valproic acid. Pol J Pharmacol 2001, 53(5):531-534.
14. Wagner G.C., Reuhl K.R., Cheh M., McRae P., Halladay A.K. A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J Autism Dev Disord 2006, 36(6):779-793.
15. Yochum C.L., Dowling P., Reuhl K.R., Wagner G.C., Ming X. VPA-induced apoptosis and behavioral deficits in neonatal mice. Brain Res 2008, 1203:126-132.
16. Ming X., Cheh M.A., Halladay A., Yochum C.L., Wagner G.C. Evidence of oxidative stress in autism derived from animal models. Am J Biochem Biotechnol 2008, 4(2):218.
17. Sogut S., Zoroglu S.S., Ozyurt H., Yilmaz H.R., Ozugurlu F., Sivasli E., et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin Chim Acta 2003, 331(1-2):111-117.
18. Banji D., Banji O.J., Abbagoni S., Hayath M.S., Kambam S., Chiluka V.L. Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals. Brain Res 2011, 1410:141-151.
19. Rice D., Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000, 108(Suppl. 3):511-533.
20. Bittigau P., Sifringer M., Genz K., Reith E., Pospischil D., Govindarajalu S., et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002, 99(23):15089-15094.
21. Brodkin E.S. BALB/c mice: low sociability and other phenotypes that may be relevant to autism. Behav Brain Res 2007, 176(1):53-65.
22. Sandhya T., Sowjanya J., Veeresh B. Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochem Res 2012, 37(5):1121-1131.
23. Choi B.M., Kim S.M., Park T.K., Li G., Hong S.J., Park R., et al. Piperine protects cisplatin-induced apoptosis via heme oxygenase-1 induction in auditory cells. J Nutr Biochem 2007, 18(9):615-622.
24. Selvendiran K., Singh J.P., Krishnan K.B., Sakthisekaran D. Cytoprotective effect of Piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice. Fitoterapia 2003, 74(1-2):109-115.
25. Wattanathorn J., Chonpathompikunlert P., Muchimapura S., Priprem A., Tankamnerdthai O. Piperine, the potential functional food for mood and cognitive disorders. Food Chem Toxicol 2008, 46(9):3106-3110.
26. Mao Q.Q., Huang Z., Ip S.P., Xian Y.F., Che C.T. Protective effects of Piperine against corticosterone-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol 2012, 32(4):531-537.
27. Fu M., Sun Z.H., Zuo H.C. Neuroprotective effect of Piperine on primarily cultured hippocampal neurons. Biol Pharm Bull 2010, 33(4):598-603.
28. Chonpathompikunlert P., Wattanathorn J., Muchimapura S. Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease. Food Chem Toxicol 2010, 48(3):798-802.
29. Schneider T., Turczak J., Przewlocki R. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 2006, 31(1):36-46.
30. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95(2):351-358.
31. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82(1):70-77.
32. Tsikas D. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 851(1-2):51-70.
33. Jacobowitz D.M., Richardson J.S. Method for the rapid determination of norepinephrine, dopamine, and serotonin in the same brain region. Pharmacol Biochem Behav 1978, 8(5):515-519.
34. Maickel R.P., Cox R.H., Saillant J., Miller F.P. A method for the determination of serotonin and norepinephrine in discrete areas of rat brain. Int J Neuropharmacol 1968, 7(3):275-281.
35. Petrosini L., Molinari M., Gremoli T. Hemicerebellectomy and motor behaviour in rats. I. Development of motor function after neonatal lesion. Exp Brain Res 1990, 82(3):472-482.
36. Rauscher F.M., Sanders R.A., Watkins J.B. Effects of Piperine on antioxidant pathways in tissues from normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2000, 14(6):329-334.
37. Gidley Larson J.C., Mostofsky S.H., Gremoli T. Evidence that the pattern of visuomotor sequence learning is altered in children with autism. Autism Res 2008, 1(6):341-353.
38. Rinaldi T., Silberberg G., Markram H. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex 2008, 18(4):763-770.
39. Schneider T., Ziolkowska B., Gieryk A., Tyminska A., Przewlocki R. Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism. Psychopharmacology (Berl) 2007, 193(4):547-555.
40. Natori T., Kodaira F., Hirasawa T., Gao Y.Y., Nagai K. Augmentation of polysialic acid by valproic acid in early postnatal mouse hippocampus and primary cultured hippocampal neurons. J Biosci Bioeng 2008, 105(2):164-167.
41. Burwell R.D., Saddoris M.P., Bucci D.J., Wiig K.A. Corticohippocampal contributions to spatial and contextual learning. J Neurosci 2004, 24(15):3826-3836.
42. Wang C., Luan Z., Yang Y., Wang Z., Cui Y., Gu G. Valproic acid induces apoptosis in differentiating hippocampal neurons by the release of tumor necrosis factor-alpha from activated astrocytes. Neurosci Lett 2011, 497(2):122-127.
43. Terranova M.L., Laviola G., Alleva E. Ontogeny of amicable social behavior in the mouse: gender differences and ongoing isolation outcomes. Dev Psychobiol 1993, 26(8):467-481.
44. Kern J.K., Jones A.M. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 2006, 9(6):485-499.
45. Thomas J.D., Goodlett C.R., West J.R. Alcohol-induced Purkinje cell loss depends on developmental timing of alcohol exposure and correlates with motor performance. Brain Res Dev Brain Res 1998, 105(2):159-166.